{"abstract":"This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR404.7(a)(1)(i), that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to practice the inventions embodied in PCT Patent Application No. PCT/US2009/054478, U.S. Patent Application No. 13/059,335 and foreign equivalents thereof entitled \"Chemopreventive of Head and Neck Squamous Cell Carcinoma\" (HHS Ref. No. E-302-2008/0) to Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd., which is located in Jerusalem, Israel. The patent rights in these inventions have been assigned to the United States of America. Other than license applications submitted as objections to this Notice of Intent to Grant an Exclusive License, no further license applications will be considered for the exclusive field of use set forth below if the Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. is granted an exclusive license pursuant to this Notice of Intent to Grant an Exclusive License. The prospective exclusive license territory may be worldwide and the field of use may be limited to use of the Licensed Patent Rights for the prevention and treatment of head and neck cancers.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2012/05/15/2012-11690.html","cfr_references":[],"citation":"77 FR 28614","comment_url":null,"comments_close_on":"2012-06-14","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the NIH Office of Technology Transfer on or before June 14, 2012 will be considered, in addition to the current non-exclusive applications under consideration, for the prospective license territory and field of use to be granted under the contemplated exclusive patent license.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2012-11690","effective_on":null,"end_page":28614,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2012/05/15/2012-11690.xml","html_url":"https://www.federalregister.gov/documents/2012/05/15/2012-11690/prospective-grant-of-exclusive-license-development-of-chemopreventive-treatments-for-head-and-neck","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2012-11690?publication_date=2012-05-15","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2012-05-15/2012-11690/mods.xml","not_received_for_publication":null,"page_length":1,"page_views":{"count":36,"last_updated":"2026-07-26 00:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2012-05-15/pdf/2012-11690.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2012-11690.pdf?1337000269","publication_date":"2012-05-15","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2012/05/15/2012-11690.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=NIH_FRDOC_0001","supporting_documents_count":0,"docket_id":"NIH_FRDOC_0001","regulation_id_number":null,"title":"Recently Posted NIH Rules and Notices.","checked_regulationsdotgov_at":"2012-06-16T05:02:34Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":28614,"subtype":null,"title":"Prospective Grant of Exclusive License: Development of Chemopreventive Treatments for Head and Neck Squamous Cell Carcinoma","toc_doc":"Development of Chemopreventive Treatments for Head and Neck Squamous Cell Carcinoma","toc_subject":"Prospective Grants of Exclusive Licenses:","topics":[],"type":"Notice","volume":77}